Monica Giovannini

Capmatinib in <i>MET</i> Exon 14–Mutated or <i>MET</i> -Amplified Non–Small-Cell Lung Cancer

Jürgen Wolf, Takashi Seto, Ji‐Youn Han et al. · New England Journal of Medicine · 2020 · 957 citations · Full text

Activity of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harboring Rare Epidermal Growth Factor Receptor Mutations

Tommaso De Pas, Francesca Toffalorio, Michela Manzotti et al. · Journal of Thoracic Oncology · 2011 · 136 citations · Full text

Medicine, Receptor Tyrosine Kinase, Pathology +7

Capmatinib (INC280) in <i>METΔex14</i>-mutated advanced non-small cell lung cancer (NSCLC): Efficacy data from the phase II GEOMETRY mono-1 study.

Juergen Wolf, Takashi Seto, Ji‐Youn Han et al. · Journal of Clinical Oncology · 2019 · 111 citations

Geometry Mono-1, Met-amplified Advanced Nsclc, Pathology +17

Large-Cell Neuroendocrine Carcinoma of the Lung Harboring<i>EGFR</i>Mutation and Responding to Gefitinib

Tommaso Martino De Pas, Monica Giovannini, Michela Manzotti et al. · Journal of Clinical Oncology · 2011 · 78 citations · Full text

Large-cell Neuroendocrine Carcinoma, Endocrine Oncology, Medicine +11

Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer

Annamaria Molino, Monica Giovannini, A. Auriemma et al. · Critical Reviews in Oncology/Hematology · 2006 · 68 citations

Surgical Oncology, Breast Oncology, Geriatrics +11